Assessment of the Taste Properties of Atazanavir and Cobicistat and Pediatric Oral Test Formulations Containing Both Atazanavir and Cobicistat in Healthy Adults
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Atazanavir/cobicistat (Primary) ; Atazanavir; Cobicistat
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 15 Feb 2018 Planned End Date changed from 31 Jul 2018 to 21 Apr 2020.
- 15 Feb 2018 Planned primary completion date changed from 30 Jul 2018 to 20 Apr 2020.
- 23 Jan 2017 Planned End Date changed from 1 Jul 2016 to 1 Jul 2018.